The global biopreservation market was valued at USD 2.18 billion in
2022 and is projected to grow at a compound annual growth rate (CAGR) of
28.30% from 2023 to 2030. The rapid growth of this market is driven by a
variety of factors, including the extensive use of biopreservation in
hospitals, research labs, and healthcare facilities. Increased funding
from both government entities and private organizations in healthcare is
bolstering this growth, alongside a rise in research and development
activities. In addition, advancements in product development are
contributing to the expanding market. For instance, BioLife Solutions
introduced a high-capacity controlled freezer in April 2021, targeting
the cell and gene therapy market, which enabled the company to extend
its product offerings.
Despite the market's expansion, the
COVID-19 pandemic posed significant challenges, such as supply chain
disruptions, shortages of raw materials, and interruptions to research
activities. However, the pandemic also accelerated the development of
novel biologics and vaccine technologies, creating a surge in demand for
biologics manufacturing and preservation. As a result, opportunities
for biopreservation are expected to increase, further boosting the
market.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Biopreservation
involves maintaining the integrity and functionality of biological
materials such as stem cells, DNA, tissues, and organs by storing them
at specific temperatures. This process extends their viability outside
of their natural environment. Recent technological innovations,
including microarrays and the incorporation of predictive models like
hybrid models and API algorithms, have significantly reduced the time,
cost, and complexity of biopreservation processes. These technological
advancements are enhancing efficiency and performance across the
industry.
Moreover, multiplex cellular imaging platforms are
emerging as a transformative technology in the biopreservation field.
These platforms improve the ability to monitor disease progression and
offer insights into suitable diagnostic and treatment measures. They are
particularly useful for specific healthcare areas like cardiology,
gynecology, and point-of-care diagnostics. As these innovations
progress, the role of biopreservation in modern healthcare is expected
to expand.
Product Segmentation Insights:
The
equipment segment dominated the biopreservation market in 2022,
accounting for 78.75% of the market share. This is largely due to the
growing demand for bio-banking services, which are used to preserve stem
cells, DNA, plasma, and tissue cultures. The ability of biopreservation
equipment to provide adequate storage capacity while requiring minimal
maintenance has contributed to the widespread adoption of these
solutions. As more healthcare providers and research facilities adopt
biopreservation technologies, the equipment segment is expected to
continue its strong performance.
The media segment, although
smaller in market share, has significant growth potential. It is a
crucial element of the biopreservation process, ensuring that biological
materials are preserved effectively. The media segment is projected to
grow at a remarkable CAGR of 29.99% from 2023 to 2030. Media
applications are becoming more sophisticated, offering features that
enhance research by enabling better data sharing and analysis. These
advancements allow researchers to improve their capabilities in
diagnosing, monitoring, and treating various health conditions, which is
expected to drive significant market growth over the forecast period.
As a result, the media segment will play an increasingly important role
in advancing the overall effectiveness and efficiency of
biopreservation.
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
Comments
Post a Comment